4
Changes in Ownership
C4 Therapeutics, Inc. Filed Acc 0001209191-21-042300
Director sold 755 shares at $37.19 ($28,078)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Salter Malcolm Director | 2021-06-18 | Sale | −755 | $37.19 | $28,078 | 14,843 | D |
| Open-market sales · 755 sh · avg $37.19 · $28,078 | |||||||
Loading xslF345X03/doc4.xml…